Skip to main content

IMMUCELL CORP /DE/

For the period ended Mar 31, 2026. Filed May 14, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 14, 2026

ICCC$10.22+4.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

March 31, 2026

Forward-Looking Statements
PART I: FINANCIAL INFORMATION
ITEM 1. · Condensed Unaudited Financial Statements
Condensed Balance Sheets as of March 31, 2026 and December 31, 20252
Condensed Statements of Income for the three months ended March 31, 2026 and 20253
Condensed Statements of Stockholders’ Equity for the three months ended March 31, 2026 and 20254
Condensed Statements of Cash Flows for the three months ended March 31, 2026 and 20255-6
Notes to Condensed Unaudited Financial Statements7-15
ITEM 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations16-18
ITEM 3.Quantitative and Qualitative Disclosures about Market Risk19
ITEM 4.Controls and Procedures19
PART II: OTHER INFORMATION
ITEM 1.Legal Proceedings19
ITEM 1A.Risk Factors19
ITEM 2.Unregistered Sales of Equity Securities and Use of Proceeds19
ITEM 3.Defaults Upon Senior Securities19
ITEM 4.Mine Safety Disclosures19
ITEM 5.Other Information19
ITEM 6.Exhibits20
Signature21
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.